a randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study

✍ Scribed by Chevalier, X.; Ravaud, P.; Maheu, E.; Baron, G.; Rialland, A.; Vergniaud, P.; Roux, C.; Maugars, Y.; Mulleman, D.; Lukas, C.; Wendling, D.; Laforgues, P.; Loeuille, D.; Foltz, V.; Richette, P.

• Book ID: 122158157
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 127 KB
• Volume: 21
• Category: Article
• ISSN: 1063-4584
• DOI: 10.1016/j.joca.2013.02.311